NovaBridge Biosciences (NBP)

SEC filing

NovaBridge Biosciences

NBP · CIK 1778016

4 · Sep 21, 2026 · Chief Medical Officer Dennis Phillip Andrew sold 8,209 shares at $0.71/share ($5,828); exercised options for 34.00K shares

Chief Medical Officer Dennis Phillip Andrew sold 8,209 shares at $0.71/share ($5,828); exercised options for 34.00K shares

xslF345X06/form4-09212026_040901.xml

xslF345X06/form4-09212026_040901.xmlSEC.gov

Graphics and non-inline formats (not embedded below).